New medical software for diabetes treatment speeds up & improves diagnoses

SINOVO health solutions GmbH presents a new medical software for diabetes treatment that supports doctors in their therapies and enables time-saving, more efficient and more precise patient care.

Bad Vilbel, 7 May 2024 - SINOVO health solutions GmbH (https://www.sinovo.de/health-apps) presents a new type of medical software for diabetology for the automated support of diagnoses and therapy decisions. In view of the limited time resources available to doctors and the complexity of diabetological treatments, this system promises more time-saving, efficient and precise patient care. The technical support systems available today are limited to the administration, editing and, if necessary, preparation of patient (measurement) data [1].

The software is a medical device of risk class IIb. The clinical studies here are extensive and time-consuming. Therefore, the novel medical software is expected to be available to doctors and diabetologists in autumn 2024 once the clinical studies have been completed.

New beneficial functions that go beyond the state of the art for patient care in diabetology

The medical software developed by SINOVO health solutions GmbH and in consultation with a medical advisory board contains beneficial functions that go beyond the state of the art for patient care in diabetology.

• Based on a comprehensive analysis of patient data, the system automatically generates precise diagnoses and therapy recommendations. These are based on a formalised set of diabetological rules and consider individual parameters such as the ambulatory glucose profile (AGP), dietary and exercise behaviour as well as medication and illnesses.
• This is the first time that a system has been developed that automatically interprets the ambulatory glucose profile (AGP) medically.
• Another new feature for treatment is that the medical software recognises inconsistencies and diabetological decision-making conflicts caused by patient data and regulations and helps to resolve them.

The doctors have the option of checking the therapy recommendations and only then accepting or rejecting them. This information will be kept in the patient's further course of therapy.

This covers the three forms of diabetes: type 1, type 2 and gestational diabetes, which account for over 95% of all diabetes cases in Germany [2].

Focus on two goals of medical software: efficient treatment times & improved treatment processes

The medical software aims to make more effective use of treatment times and optimise treatment processes. ‘Our aim is to relieve doctors in their daily work and at the same time improve the quality of diabetes treatment in line with the corresponding quality optimisation requirements of health insurers,’ explains Jan Filip, one of the two managing directors of SINOVO health solutions GmbH. How good diabetes care can be today and tomorrow and modern technologies are also topics of the Diabetes Congress of the DDG from 8 - 11 May 2024 in Berlin (https://diabeteskongress.de/programm/).

With an average time of only around 7.6 minutes [3] for a patient contact and the large volume of patient data collected on a quarterly basis, it is often not possible to make optimal treatment decisions reliably. The treatment time is often too short to be able to analyse all the patient data available since the last patient visit, especially:

• the ambulatory glucose profile (AGP) [4],
• the HbA1c value [5],
• the insulin doses,
• information on diet, exercise, alcohol consumption, medication, etc. (depending on availability),

systematically considered when making treatment decisions.

Case Study: Time savings in a diabetological practice in Germany

A typical use of the system in a diabetology practice in Germany shows a time saving of around 7.5 minutes per patient and session: 5 minutes for analysing patient data and 2.5 minutes for finding the appropriate treatment recommendation. On average, a diabetologist treats around 30 patients a day [6]. They could therefore save approx. 30 x 7.5 minutes = 225 minutes or just under 4 hours per day.

This time can now be used more effectively for making informed treatment decisions and counselling patients.

Conclusion: Initial approval for the German market & sustainable improvement in diabetological care

‘With our system, we want to make a contribution to improving patient care and relieving the burden on doctors,’ emphasises Filip. ‘We are convinced that this innovation will sustainably improve diabetological care.’

Due to the different national therapy guidelines for diabetes, the new product is initially intended primarily for the German market. In view of the 9 million diabetes patients in Germany [7] and around €38.5 billion [8] in diabetes-related costs (total healthcare expenditure in Germany: almost €500 billion [9]), the German market already has a considerable volume.

SINOVO Group

For 25 years, SINOVO has been offering corporate customers customised software development, IT infrastructure design including IT security, development of digital health applications (DiGA), quality management services and software testing across all industries. With our ISO 13485 and ISO 9001 certified quality management system, our ISO 27001 certification for information security management systems and our certification as a Microsoft partner, we ensure that our solutions meet your high quality standards.

Press contact

SINOVO Group, Tanja Schönfeld, Willy-Brandt-Str. 4, 61118 Bad Vilbel, Tel.: +49 6101 590 90 00, E-Mail: presse@sinovo.de , Web: sinovo.de

References

[1] Patentrecherche in Google Patents

[2] Bundesministerium für Gesundheit: Diabetes mellitus Typ 1 und Typ 2, abgerufen am: 29.04.2024, https://www.bundesgesundheitsministerium.de/themen/praevention/gesundheitsgefahren/diabetes#:~:text=Medizinisch%20unterscheidet%20man%20verschiedene%20Diabetes,Typ%2D2%2DDiabetes%20erkrankt

[3] Hanke, Stefanie: Der Nächste bitte: Arzt-Patienten-Kontakte im internationalen Vergleich , abgerufen am 29.04.2024, https://aerztestellen.aerzteblatt.de/de/redaktion/arzt-patienten-kontakte-im-internationalen-vergleich

[4] AGP = Ambulatory Glucose Profile. Der sogenannte AGP-Bericht ist ein genormter Bericht des Blutzuckerspiegels über einen Zeitraum von bspw. zwei bis vier Wochen. Er stellt den Median der (quasi-) kontinuierlich gemessenen Glukosewerte zusammen mit ihrer Variabilität dar. Siehe z.B. https://www.diabetologie-online.de/a/cme-fortbildung-ambulantes-glukoseprofil-agp-auswerten-2045155

[5] Der HbA1c-Wert gibt Auskunft über die durchschnittlichen Glukosewerte der letzten zwei bis drei Monate. Siehe z.B.: https://www.diabetes-ratgeber.net/Blutzucker/Der-HbAlc-Wert-Das-Blutzuckereedaechtnis-54134 3.html

[6] Prof. Dr. med. Kellerer, Monika: Die Diabetologie ist das klassische Querschnittsfach, abgerufen am: 29.047.2024, https://arztundkarriere.com/weiterbildung/weiterbildung-diabetologie/

[7] ÄrzteZeitung: Steigende Inzidenz - Deutsche Diabetes Gesellschaft zählt neun Millionen Diabetespatienten, abgerufen am: 29.04.2024, https://www.aerztezeitung.de/Politik/Fachgesellschaft-zaehlt-mittlerweile-neun-Millionen-Diabetespatienten-446459.html

[8] Deutsche Diabetes Gesellschaft (DDG) und diabetesDE – Deutsche Diabetes-Hilfe: Deutscher Gesundheitsbericht Diabetes 2024 - Die Bestandsaufnahme, abgerufen am: 29.04.2024, https://www.ddg.info/fileadmin/user_upload/Gesundheitsbericht_2024_Endversion.pdf

[9] DeStatis: Gesundheitsausgaben im Jahr 2022 auf knapp 500 Milliarden Euro gestiegen, abgerufen am 29.04.2024, https://www.destatis.de/DE/Presse/Pressemitteilungen/2024/04/PD24_167_236.html